DevR-DevS (Rv3133c-Rv3132c) and DevR-Rv2027c have been established through their autophosphorylation and phosphotransfer properties to constitute bonafide regulatory 2-component systems of Mycobacterium tuberculosis. DevR has also been shown by others to play a key regulatory role in the expression of M. tuberculosis genes comprising the dormancy regulon. The authors describe high-throughput phosphorylation assays in a microplate format using DevS and Rv2027c histidine kinases and DevR response regulator proteins from M. tuberculosis. The assays were designed to measure [γ-32 P]ATP-dependent autophosphorylation of DevS/Rv2027c and also the phosphotransfer reaction to DevR. First, the optimal reaction conditions were established using the conventional method of radiolabeling the 2-component proteins by [γ-32 P]ATP and followed by gel electrophoresis-based analysis. Next, the assays were converted to a high-throughput format in which the radiolabeled protein retained on a filter using mixed cellulose ester-based 96-well filter plates was analyzed for radioactivity retention by scintillation counting. The utility of these assays to screen for inhibitors is illustrated using 2-mercaptobenzimidazole, ethidium bromide, and EDTA. The high quality and flexibility of these assays will enable their use in high-throughput screening for new antitubercular compounds directed against 2-component systems that comprise a novel target in dormant mycobacteria. (Journal of Biomolecular Screening 2005:215-224) 
I T IS ESTIMATED that one-third of the world's population is infected with Mycobacterium tuberculosis, with 8 million new cases of active tuberculosis and 2 to 3 million deaths occurring every year. 1 The consequence of tuberculosis infection is an outcome of the dynamic interplay between the pathogen and the host immune defense. In most instances, the infected individual mounts an effective immune response that culminates in granuloma formation around infective foci and cessation of disease progression. Clinical studies suggest that the bacilli within these granulomas are not killed but instead remain dormant in untreated individuals, causing latent infection that can last a lifetime. [2] [3] [4] Approximately 10% of latent infections reactivate, resulting in active disease months to years after the initial infection. 4 Tuberculosis control programs are directed toward finding infectious cases and putting them on treatment. The current chemotherapeutic regimens target rate-limiting steps in metabolic pathways and enzymes that are unique to prokaryotes such as cell-wall biosynthesis (e.g., isoniazid) and RNA synthesis (e.g., rifampicin). These classes of drugs have maximal activity against actively dividing bacilli. Their low efficacy against slow-growing and nonreplicating tubercle bacilli could explain why treatment regimens take so long to eradicate infection. 1 There are 3 main reasons to identify and develop new antitubercular drugs, and these obviously stem from the drawbacks in existing antitubercular therapy: 1) to improve current treatment by shortening the total duration of treatment and/or by providing for more widely spaced intermittent treatment, 2) to improve the treatment of multi-drug-resistant tuberculosis, and 3) to provide an effective treatment for latent tuberculosis infection.
Although no new drugs for tuberculosis have been introduced in the market in the past 30 years, some lead compounds targeted against the conventional drug targets are currently being tested. The discovery of genes that play key roles in mycobacterial persistence has paved the way for the identification of molecules in persisting bacteria that can be targeted by new classes of drugs. Twocomponent regulatory systems belong to this class of novel tar-gets. 5, 6 These bacterial signaling systems play a major role in their adaptation to the environment. In its most basic from, a 2-component system consists of a sensor kinase that undergoes adenosine triphosphate (ATP)-dependent autophosphorylation at a conserved histidine residue and a response regulator that is subsequently phosphorylated at a conserved aspartic acid residue in a phosphotransfer reaction. 7 These systems are required not only in adaptation to environmental changes but also for virulence and differentiation. 8, 9 Mycobacterial 2-component systems have not been exploited for developing antimycobacterial agents so far. The physiological significance of the DevR response regulator has been amply demonstrated. We and others have shown DevR-DevS/Rv2027c to comprise authentic 2-component signaling systems in M. tuberculosis. [10] [11] [12] [13] DevR has been shown to be vital for mycobacterial survival in hypoxic conditions. 14 Its role as a transcriptional regulator of the hypoxia response in M. tuberculosis has been demonstrated. 15 Also, exposure of cells to nitric oxide induces the hypoxia response in a DevR-dependent manner. 16 These findings are of crucial importance because it is believed that the environmental cues of hypoxia and nitric oxide might contribute to latency in vivo. 16 The role of DevR in cultured bacilli is backed by guinea pig infection data that demonstrate its involvement in M. tuberculosis virulence. 17 However, a devR knockout strain was reported by another laboratory to be hypervirulent in mice. 18 The contradictory findings in the mouse infection model 18 could be due to inherent differences in the 2 mutant strains, in the experimental models and the route of infection used (discussed in Malhotra et al. 17 ). For these reasons, DevR is considered to be a crucial regulator of the dormancy response of M. tuberculosis.
Intercepting the DevR-DevS/Rv2027c signaling pathways could thus prevent the establishment of dormancy in freshly infected persons and also disrupt the maintenance program in latently infected individuals. Therefore, assays to identify inhibitors of DevR-DevS/Rv2027c will be of relevance to the drug discovery process. In combination with conventional therapy, these novel moieties in principle could eradicate replicating tubercle bacilli and block the establishment of dormant bacilli in latent tuberculosis. Against this background, biochemical assays employing DevR, DevS, and Rv2027c provide a potent means of identifying novel antitubercular chemotherapeutic agents. Phosphorylation assays have been developed using DevS, Rv2027c, and DevR. By employing the statistical parameter Z′, 19 the assays were judged to be of high quality and suitable for high-throughput screening (HTS) of inhibitor compounds targeting DevR-DevS/Rv2027c regulatory systems.
MATERIALS AND METHODS

Materials
The cytoplasmic domains of histidine kinases DevS (DevS 201 ) and Rv2027c (Rv2027c 194 ) and the full-length response regulator DevR were overexpressed as N-terminally His 6 -tagged proteins and purified as reported. 10, 11, 20 At least 2 lots of each protein were used in assay development. Henceforth, for convenience, DevS 201 and Rv2027c 194 are referred to as DevS and Rv2027, respectively. [γ-32 P]ATP (specific activity 3000 Ci mmol -1 ) was obtained from BRIT (Jonaki, India); Multiscreen-HA 96-well plates, the filtration device (Multiscreen Resist Vacuum Manifold), and the filter removal device (Multiscreen Multi Punch) were procured from Millipore India.
Autophosphorylation of sensor kinases
Autophosphorylation was essentially performed according to the published procedures. 10, 11 Briefly, DevS or Rv2027 was incubated in 10 µl buffer containing 50 mM Tris.Cl, pH 8.0, 50 mM KCl, 25 mM MgCl 2 , 50 µM ATP and 2.5 µCi of [γ-32 P]ATP at 25°C for 60 min in 0.5-ml microfuge tubes. DevS and Rv2027 were used at final concentrations of 30 µM and 21 µM, respectively. The reactions were stopped with 5 µl of stop buffer containing 250 mM Tris-HCl, pH 6.8, 10% glycerol, 1% sodium dodecyl sulphate (SDS), 280 mM β-mercaptoethanol, and 0.01% bromophenol blue, and the reaction mix was subsequently analyzed by 12.5% SDS-polyacrylamide gel electrophoresis (PAGE) followed by rinsing of the gel twice in water and autoradiography for 16 h at 4°C. The optimum concentration of DevS/Rv2027 in the reaction was determined as described above in the presence of 2.5 µM to 35 µM of the protein.
Coupled assay of autophosphorylation and phosphotransfer reactions
The coupled assay was performed in 2 steps. In step 1, the histidine kinase (DevS, 30 µM and Rv2027, 21 µM final concentration) was phosphorylated as described above. In step 2, DevR protein (14 µM) was added to the same well/tube, and the mixture (final reaction volume 15 µl) was further incubated for 25 min at room temperature and was subsequently processed as described above. The optimum concentration of DevR in the phosphotransfer assay was determined in the presence of 4.5 to 25 µM of the protein. In the assay containing EDTA, DevR (14 µM) was preincubated with EDTA (50 mM) for 30 min at room temperature before the addition of phosphorylated histidine kinase reaction mixture.
Assays in 96-well format
The autophosphorylation reaction was performed in U-bottom 96-well microplates for 60 min at room temperature in 10 µl reaction volume as described above and stopped by dilution with 200 µl of cold phosphate-buffered saline (PBS). The diluted contents were promptly transferred to a 96-well MultiScreen HA-plate prewetted with PBS and processed by high-throughput filtration using the vacuum manifold/device to remove the reaction components and trap the proteins on the membrane. The wells were washed 3 times with 300 µl PBS using the vacuum manifold. The filters were subsequently dried on the vacuum for 2 min at room temperature, and individual filters were cut using the filter removal device. The radioactivity retained on each filter was quantitated in 32 P channel by liquid scintillation counting in Optisync HiSafe ® scintillation fluid (NEN, Wallac) in a β counter (Wallac Inc., Gaithersburg, MD). In case of phosphotransfer reactions, DevR was directly added to the autophosphorylation reactions in the microplate, and 15-µl reactions were incubated at room temperature for a further 20 min. The reactions were stopped by adding 20 volumes of PBS and processed thereafter by filtration as described above.
Effect of 2-mercaptobenzimidazole and ethidium bromide on autophosphorylation
DevS and Rv2027 proteins were preincubated in reaction buffer (without ATP) with a range of concentrations of 2mercaptobenzimidazole (2-MBI) or ethidium bromide dissolved in DMSO or water, respectively, for 30 min at room temperature. Autophosphorylation was initiated by the addition of ATP and analyzed as described above.
Determination of assay quality
Signal/noise, signal/background and Z′ factor were calculated as described. 19 Signal/noise = mean positive signal -mean background signal/standard deviation of background signal; signal/ background = mean positive signal/mean background signal; Z′ = (3σ c+ + 3σ c-)/µ c+ -µ c-; where positive signal is the radioactivity retained on the filter in the complete autophosphorylation/ phosphotransfer reaction, background signal is the radioactivity retained in the presence of only DevR + ATP or BSA + ATP (without histidine kinase), σ is standard deviation, µ is the mean, c+ is the positive signal, and c-is the background signal.
RESULTS
DevS/Rv2027 autophosphorylation
The cytosolic catalytic domains of the histidine kinases, DevS and Rv2027, were used in the phosphorylation reaction because of the relative ease of overexpressing them over their full-length species. 20, 21 Briefly, the C-terminal region of DevS and Rv2027 (of 201 and 194 amino acids length, respectively), which were deleted of their N-terminal 377 and 379 amino acid residues, respectively, and full-length DevR (217 amino acids) were expressed as Nterminally His 6 -tagged proteins in Escherichia coli. 10, 11 Figure 1 gives a schematic overview of the phosphorylation cascade involving DevS, Rv2027, and DevR that can be subdivided into 4 steps: signal sensing by DevS/Rv2027 (steps 1a and 1b), its autophosphorylation at a conserved histidine residue (steps 2a and 2b), phosphotransfer to a conserved residue in DevR (step 3), and modulation of DevR DNA-binding activity (step 4). Interception at any of these steps could block signaling and prevent an appropriate adaptive response in M. tuberculosis.
An understanding of the properties of these proteins at the biochemical level provided the means of using the catalytically active cytosolic domains of DevS and Rv2027 and full-length DevR in high-throughput phosphorylation assays (steps 2a, 2b, and 3) for inhibitor screening. In 60 min, the autophosphorylation of DevS and Rv2027 occurred to~80% and~60%, respectively, of the maximum radioactivity incorporated into the protein (tested up to 24 h) and yielded stable phosphorylated species. The conserved histidine residue at position 395 in DevS and 392 in Rv2027 was confirmed by site-directed mutagenesis to be the site of phosphorylation. 10, 11 At first, the microplate assay was standardized to determine the optimal reaction conditions and washing parameters during filtration. The reactions were incubated for 60 min to enable labeling of DevS and Rv2027 to levels that are sufficiently above the detection threshold.
The reaction was optimized with respect to protein, MgCl 2 , and ATP concentration. While developing the assay in plate format, its performance was assessed simultaneously in SDS-PAGE and filter plate formats. The optimal concentration of DevS and Rv2027 proteins in the autophosphorylation reaction was determined to be 30 µM and 21 µM, respectively (Fig. 2) . In subsequent highthroughput reactions, DevS and Rv2027 were used at these concentrations unless mentioned otherwise. Mg +2 is necessary for autophosphorylation of histidine kinases. 22 Its use during autophosphorylation was examined; DevS autophosphorylation showed a linear increase with an increase in MgCl 2 concentration, whereas Rv2027 showed peak incorporation at 1 mM, and the efficiency of autophosphorylation decreased in the presence of higher and lower concentrations of MgCl 2 (Fig. 3 ). To optimize ATP concentration, the assay was performed in the presence of a range of ATP concentrations (10, 25, and 50 µM cold ATP and 5 µCi of [γ-32 P]ATP); 10 µM was judged to be the optimum concentration (not shown). Thereafter, all assays were performed using 10 µM ATP and 2.5 µCi [γ-32 P]ATP (to reduce usage of radioactivity). The filtration conditions were also standardized; wash buffers that were evaluated included 50 mM Tris-HCl pH 8.0-50 mM KCl-25 mM MgCl 2 (with or without EDTA at 50 mM concentration) and PBS. Three washes with PBS gave consistently low background values and were used in all further assays. The data from the SDS-PAGE assay closely mirrored those from the microplate assay as seen in Figures  2 and 3 . The presence of glycerol in the final reaction (derived from the enzyme solution) up to~35% did not interfere with the reaction.
High-throughput coupled assay involving autophosphorylation and phosphotransfer in plate format
The phosphotransfer assay is based on interaction of DevR with the histidine kinase and phosphorylation of a conserved aspartic acid residue at position 54 in DevR. 10, 11 We assume that when employed in inhibitor screening, the inhibitors would act by binding DevR and not DevS/Rv2027 (unless binding to the histidine kinase would prevent phosphotransfer to DevR or dephosphorylation of DevR). It was earlier shown by SDS-PAGE assays that phosphotransfer occurred rapidly from DevS to DevR; the maximum signal in DevR~P was obtained within 2 min of DevR addi- tion. Thereafter, there was a time-dependent loss of net proteinbound radiolabeled phosphate, and dephosphorylation of both proteins was nearly complete within 10 min. 10, 11 Moreover, as the concentration of DevR was increased in the phosphotransfer reaction, there was a proportionate increase in the extent of dephosphorylation of DevS~P within a 25-min period (Fig. 4) . A similar observation was also made in Rv2027-mediated phosphotransfer (not shown). This property was advantageously used to set up a phosphotransfer assay. These observations were reproduced in the microplate assay; in the presence of increasing concentrations of DevR (4.5-25 µM), the net radioactivity retained on the filter was diminished in a DevR concentration-dependent manner in comparison to the reactions wherein no DevR was added ( Fig. 5 ). Thus, because DevR~P is a rather labile species in the presence of DevS/Rv2027 and itself undergoes rapid dephosphorylation, 8, 9 we used this property to monitor phosphotransfer. A typical phosphorelay reaction in the presence of optimum concentration of DevS/Rv2027 (30 µM/21 µM) and DevR (14 µM) is shown in Figure 6 . When DevR was added to phosphorylated histidine kinase and incubated further at room temperature for 25 min (time point chosen on the basis of previous characterization), radioactivity associated with the proteins decreased by 85% and 77% due to rapid phosphotransfer from DevS and Rv2027, respectively, to DevR and subsequent dephosphorylation of DevR itself (Fig. 6 ).
Characteristics of the microplate format assays
The quality of the screening assays was assessed by determining signal-to-noise and signal-to-background ratios as well as the Z′ factor. 19 The Z′ factors for DevS and Rv2027 autophosphorylation were 0.83 and 0.85, respectively, and the Z′ factor for the DevR-coupled assays was 0.62 (Table 1 ). We conclude that the autophosphorylation and phosphotransfer assays developed in this study are of very high quality and can be used for screening test compounds with a great degree of accuracy. The final reaction contents were incubated at room temperature for an additional 20 min to allow for phosphotransfer to DevR and subsequent dephosphorylation of both proteins, after which the reaction contents were filtered and processed as described. The control reaction (right side) contained DevR plus adenosine triphosphate (and no histidine kinase) and showed minimal protein labeling. Cpm ± standard deviation retained from triplicate wells is plotted. Auto = autophosphorylation; trans = phosphotransfer.
Utility of the autophosphorylation and coupled assays in inhibitor screening
The utility of these assays in screening for autophosphorylation inhibitors was investigated using selected compounds, namely, 2-MBI and ethidium bromide. Benzimidazoles are reported to have many clinical applications as antiulcerative, antimicrobial, antifungal, and antihelminthic agents. 23, 24 For example, 2phenylbenzimidazole was reported to inhibit autophosphorylation of KinA sensor kinase. 25 In our assays, the IC 50 of 2-MBI was 0.5 mM for both DevS and Rv2027 (Fig. 7A) . The inhibition was considered to be specific, as the presence of DMSO at a concentration up to 40% did not inhibit autophosphorylation. Autophosphorylation of DevS and Rv2027 was also inhibited by ethidium bromide, a compound that is moderately toxic, strongly mutagenic, and potentially carcinogenic. Its chief medical application has been in the treatment of trypanosome infections in cattle, 26 and it is widely used in fluorescent staining of nucleic acids. Its IC 50 for Rv2027 was 0.6 to 0.7 mM, whereas that for DevS exceeded 2.5 mM, the highest concentration tested (Fig. 8A) . Inhibition of the autophosphorylation reaction was confirmed by analyzing the phosphorylated reaction products in parallel in the SDS-PAGE format (Figs. 7B, 8B) . At present, it is unclear how these compounds inhibited DevS/Rv2027 other than by targeting the kinase domain. Because 2-MBI and ethidium bromide did not inhibit phosphotransfer (not shown), we used EDTA as a quasi-inhibitor to demonstrate the utility of the coupled assay in inhibitor screening. We have shown earlier 10, 11 that phosphotransfer is completely dependent on Mg 2+ . As EDTA chelates Mg 2+ , it was expected to inhibit phosphotransfer; in its presence, the radiolabel was retained by the histidine kinase whereas in reactions containing histidine kinase plus DevR (and no EDTA),~85% and~77% reduction in label was noted ( Fig. 6 ). In a control reaction containing DevR plus ATP (and no histidine kinase), the protein was not labeled (Fig. 6 , right data bar), excluding the possibility of direct labeling of DevR by ATP. Although the mechanism of EDTA action could involve inhibition of phosphotransfer, loss of label from DevR~P, or both, the utility of the assay to identify DevR inhibitors is clearly demonstrated.
DISCUSSION
The unique reaction kinetics of the DevR/DevS and DevR/ Rv2027 systems together with the ease of producing these proteins in large quantities in E. coli 10, 11, 20 provided the means to develop microplate assays for rapid screening of compound libraries for inhibitors of both autophosphorylation and phosphotransfer reactions. This is the first report of an assay for screening for inhibitors of the phosphotransfer reaction in a coupled assay system. The reaction conditions initially standardized in the SDS-PAGE format were optimized in the plate format and provided identical results, pointing to the reliability and flexibility of the assays. The [γ-32 P]ATPbased plate assays are completely automatable using robotic platforms and discount the perceived disadvantages of handling radioisotopes. The use of [γ-33 P]ATP in place of [γ-32 P]ATP will minimize radiation hazards due its less potent β-irradiation. A previous publication described a high-throughput autophosphorylation assay in which phosphorylation of CheA histidine kinase from E. coli at a conserved histidine residue was quantitated in a 96-well filter plate-based assay. 27 It was also a radioactive assay except that [γ-33 P]ATP was used (in place of [γ-32 P]ATP in this assay).
In the research laboratory setting, our assays are composed of 4 steps: cocktail preparation and dispensing in microplate wells, incubation and stopping the reaction by dilution in excess of PBS, transfer to 96-well filter plates and filtration, and cutting and counting the filters (Fig. 9 ). The assays should be easily amenable to automation and retain their reliability as the Z′ factors were large, which is considered to be indicative of high overall assay quality. 19 Although the assays have not been used to screen compounds, we believe that they should be amenable for screening libraries prepared in DMSO with which the assays are completely compatible up to a concentration of 40% DMSO. In an average 8-h work cycle involving 1 person and 1 automatic liquid handling system, approximately 3500 to 4000 compounds can be screened per day per assay (Fig. 8) .
A large number of compounds has been discovered from compound library screens that inhibit kinase activity and also exhibit antibacterial activity. 6, 28, 29 However, the majority of these inhibitors suffer from excessive protein binding and/or limited bioavailability and have multiple mechanisms of action including bacterial membrane-damaging and surfactant properties 25 and structural alterations of the histidine kinases leading to aggregation. 30 Therefore, these compounds were not as selective as was originally thought and did not exhibit a strong correlation between their IC 50 s against 2-component systems and minimum inhibitory concentration against bacteria. 6, 28 Nonspecific interaction of the compounds with proteins unrelated to their molecular target has been suggested as a possible explanation 31 in addition to aggregate formation leading to nonspecific inhibition. 32, 33 It is hoped that use of the coupled assay for screening will lead to the identification of lead molecules that inhibit phosphotransfer, a reaction that is relatively unexplored for inhibitor screening.
Between the histidine kinase and response regulator, the latter is likely to be the superior target for inhibition on account of its terminal position in the signaling cascade, its key role as a transcription regulator, and its ability to be phosphorylated by more than 1 sensor, as demonstrated in the case of DevR. 10, 11, 17 There is an inherent difficulty in using a coupled assay in a filter-based format owing to an inability to discriminate between the phosphorylated species of the histidine kinase and response regulator. Inhibitors of 2-component systems that inhibited the activity of AlgR1 and AlgR2 proteins regulating alginate biosynthesis in Pseudomonas aeruginosa were discovered using an algD-xylE reporter assay. 34 Some of these inhibitors also showed phosphoryltransferase inhibitory activity against VanR of Enterococcus faecium in an SDS-PAGE assay format. 35 However, 1) because the phosphorylated species of DevS and Rv2027 are very stable but rendered unstable in the presence of DevR to which they rapidly transfer the phosphoryl moiety 10, 11 and 2) because DevR~P is extremely unstable in the presence of DevS/Rv2027, 10, 11 these proteins are eminently suited for rapid filter-based inhibitor screens of both autophosphorylation and phosphotransfer. As DevS and Rv2027 do not undergo spontaneous autodephosphorylation, 10,11 the probability of missing a hit because of their dephosphorylation is also very low. Likewise, retention of the label in the coupled assay would indicate the presence of a molecule targeting the phosphotransfer reaction (or DevR-directed DevS/Rv2027 phosphatase activity).
Although histidine/aspartate 2-component signal transduction systems are present not only in bacteria but also in fungi and plants, they are distinct from the Ser/Thr signaling pathways used by eukaryotes including mammals. Therefore, the drugs that inhibit these 2-component systems are expected to specifically target bacteria and not human beings. Furthermore, sensor kinases and response regulators are highly conserved, particularly around the active sites that are likely to be shared between several 2-component system proteins. 22 These attributes combined with the presence of 2-component systems in a large number of bacteria, including mycobacteria, suggest that selective inhibitors directed against DevS/ Rv2027 could potentially target several signal transduction systems. Cell infection and animal models have shown that many proteins of this class, MprA, PhoP, DevR, KdpDE, TcrXY, TrcS, and SenX3-RegX3, play a role in the survival and multiplication of M. tuberculosis. 15, 16, [36] [37] [38] [39] [40] Thus, multiple signaling systems could be inhibited by a single molecule targeting the active sites of sensor kinases or response regulators and interfere with pathways vital for M. tuberculosis survival within host tissues. Remove individual filters from the plate and count retained activity or add scintillation fluid to individual wells and count for activity retention in each well Inhibitor for step 3 (Fig. 1 ) Inhibitor for step 2a and 2b (Fig. 1)   FIG. 9 . Proposed screening strategy in 96-well microplate format for inhibitors of autophosphorylation and phosphotransfer reactions involving sensor kinases and response regulator proteins. ATP = adenosine triphosphate; RT = room temperature.
CONCLUSIONS
High-throughput microplate-based assays were developed to measure the autophosphorylation and phosphotransfer activity of 2-component system proteins DevS, Rv2027c, and DevR of M. tuberculosis. Their utility was demonstrated using selected compounds. The high quality of the assays and their suitability for HTS was established using the Z′ factor as a parameter.
